Contact: Carl Graziano
Director, Strategic Communications
DMAA Approves New Board Appointments, Titles
WASHINGTON, D.C.—The Disease Management Association of America (DMAA) this week approved new and current Board of Directors members and, with the appointments, established new titles for several key leadership positions.
During a business meeting Dec. 5 at the Disease Management Leadership Forum (DMLF), in Denver, DMAA members approved the appointment of William Popik, MD, as the association's new Chairman. Previously, the top Board position held the title of President. Outgoing President Christobel Selecky, Executive Chairman of LifeMasters Supported SelfCare Inc., will become Immediate Past-Chair.
DMAA also created a new "At Large" Board officer position and appointed current Board member Jack Mahoney, MD, to it. Dr. Mahoney is Corporate Medical Director for Pitney Bowes Inc. Tracey Moorhead, the association's chief staff officer, will change her title from Executive Director to President and Chief Executive Officer.
Other Executive Committee slots announced at the DMLF were:
Treasurer, Jaan Sidorov, MD, MHSA, Medical Director, Care Coordination, Geisinger Health Plan
Secretary, Paul Wallace, MD, Executive Director, Care Management Institute, Kaiser Permanente
Chair, Government Affairs Committee, Jan Berger, MD, Chief Medical Officer, Caremark Rx Inc.
Chair, Quality and Research Committee, Gordon K. Norman, MD, MBA, Executive Vice President and Chief Medical Officer, Alere Medical Inc.
DMAA also approved new Board members for three-year terms, including:
Ken McDonough, MD, Medical Director, AstraZeneca Pharmaceuticals
David B. Nash, MD, MBA, Dr. Raymond C. and Doris N. Grandon Professor of Health Policy Chair, Department of Health Policy, Jefferson Medical College
Samuel R. Nussbaum, MD Executive Vice President & Chief Medical Officer, Wellpoint
Freida Outlaw, RN, PhD, Deputy Commissioner, Department of Mental Health, State of Tennessee
James Pope, MD, FACC, Chief Operating Officer, Healthways Inc.
Susan B. Riley, Chief Executive Officer, AirLogix, Inc.
Alex R. Rodriguez, MD, Medical Officer, Harmony Behavioral Health Inc., WellCare Health Plans Inc.
Tehseen Salimi, MD, MHA, Medical Director, Managed Care, sanofi-aventis
John Sory, Vice President, Pfizer Inc.
Janet S. Wright, MD, Chair, Disease Management Committee, American College of Cardiology
Board members who filled their maximum terms of service are outgoing Quality and Research Committee Chair Donald Fetterolf, MD, and Government Affairs Committee Chair Sandeep Wadhwa, MD. Dr. Fetterolf will continue in a leadership position as Co-Chair of the DMAA Outcomes Steering Committee, which produced consensus guidelines this for release at this year's DMLF. A second phase of the guidelines project will begin in January.
# # #
The Disease Management Association of America (DMAA) a non-profit membership association, represents all stakeholders in disease management and care coordination. DMAA promotes the role of disease management in raising the quality of care, improving health outcomes and reducing health care costs for individuals with chronic conditions. DMAA has more than 200 corporate and individual members representing all aspects of disease management and care coordination—from large health plans, disease management organizations and employers, to individual physicians, researchers and nurses. Learn more by visiting DMAA online at www.dmaa.org.
Visit our new portal to log in for access to your Care Continuum Alliance profile and members-only content and services.
Chronic Care Professional Certification—Member Discounts Now Available.
Learn how Chronic Care Professional certification, available at a discount to Care Continuum Alliance members through a special partnership with the HealthSciences Institute, brings valuable benefits to you and your organization. Go >>
Advocacy, research, education and more—the value of Care Continuum Alliance membership is clear. Learn more about who we are and the benefits our corporate and individual members receive.